Author | Mallory Norman, BS, PharmD Candidate and Lisa M. Holle, PharmD, BCOP, FHOPA

Articles

Entrectinib for ROS1-Positive NSCLC and NTRK-Positive Solid Tumors

May 08, 2020

In August 2019, the FDA approved entrectinib for treatment of adult patients with metastatic non-small cell lung cancer that is ROS1-positive.